Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00942877 |
|---|---|
| Brief Title: | Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma |
| First Submitted : | July 18, 2009 |
| First Submitted that Met QC Criteria : | July 18, 2009 |
| First Posted : | July 21, 2009 (Estimate) |
| Results First Submitted : | March 2, 2021 |
| Results First Submitted that Met QC Criteria : | April 6, 2021 |
| Results First Posted : | April 27, 2021 |
| Last Update Submitted that Met QC Criteria : | February 15, 2024 |
| Last Update Posted : | March 12, 2024 |